Showing results (141-150 of 242) with videos related to
Sort By:
Pageof 25
Cancer|March 27, 2018
Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP)Fred R Hirsch, Lecia V Sequist, Ira Gore, et al.Anticancer Research|April 13, 2016
HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group StudyThomas Makatsoris, Athanassios C Tsamandas, Alexios Strimpakos, et al.Cancer Research|June 29, 2012
Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibitionMatias Casás-Selves, Jihye Kim, Zhiyong Zhang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2019
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation ConsortiumRobin Guo, Lynne D Berry, Dara L Aisner, et al.Molecular Cancer Research : MCR|August 1, 2006
Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell linesChristopher D Coldren, Barbara A Helfrich, Samir E Witta, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2017
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the LungSinead A Noonan, Tejas Patil, Dexiang Gao, et al.The Oncologist|September 3, 2015
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based RecommendationsBenjamin P Levy, Marc D Chioda, Dana Herndon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expressionRafal Dziadziuszko, Daniel T Merrick, Samir E Witta, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancerAndrew J Weickhardt, Benjamin Scheier, Joseph Malachy Burke, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 23, 2023
Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjectsSteinn Jonsson, Wilbur A Franklin, Marileila Varella-Garcia, et al.Pageof 25